Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma

RESEARCH TRIANGLE PARK, N.C., Aug. 5 /PRNewswire/ -- Addrenex Pharmaceuticals, a specialty pharmaceutical company dedicated to developing treatments to regulate the adrenergic system, announced today an exclusive partnership with Dream Pharma. In keeping with its long-range plan to ...

Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola

MONHEIM, Germany and ST. LOUIS, June 29 /PRNewswire/ -- Bayer CropScience AG and Monsanto Company have agreed to cross license their respective herbicide tolerance traits in rapeseed/canola on a non-exclusive basis for commercialization within their respective branded canola seed businesses. Cano...

KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter

ST. LOUIS and BUDAPEST, Hungary, June 18 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that it has entered into an agreement with Gedeon Richter, Plc. of Budapest, Hungary, and jointly with Gedeon Richter USA for licensing rights to certain of KV's technologie...

Gaiam and Discovery Communications Announce Exclusive Licensing Deal

NEW YORK, June 16 /PRNewswire-FirstCall/ -- Gaiam, Inc., the leading distributor of lifestyle media and fitness accessories, today announced that it has signed an exclusive home video license agreement with Discovery Communications. Under the three-year agreement, Gaiam will release programming fr...

InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early

OXFORD, England, May 18 /PRNewswire/ -- PharmaVentures Ltd, announced today that it has been engaged by InDex Pharmaceuticals AB to advise and assist in out-licensing its first in class therapeutic, Kappaproct (DIMS 0150), for the treatment of steroid resistant / dependent Inflammatory Bowel Disea...

MMR Information Systems, Inc. Receives Licensing Proposal Involving the Company's Anti-CD20 Antibodies

LOS ANGELES, May 15 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: MMRF) (the "Company"), which was known as Favrille, Inc. until it acquired its subsidiary MyMedicalRecords, Inc. ("MMR") in January 2009, announced today that it had received a proposal to license cer...

Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement

SAN MARCOS, Calif., March 9 /PRNewswire-FirstCall/ --Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII ), a leading formulator and manufacturer of customized nutritional supplements, and Compound Solutions, Inc. ("CSI"), a science and marketing based distributor of raw materials to ...

Teikoku Pharma USA and Eisai Co., Ltd. Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil.

SAN JOSE, Calif., March 9 /PRNewswire/ -- Teikoku Pharma USA Inc., the international specialty pharmaceutical company, announces that it has signed an exclusive worldwide (excluding Japan) licensing agreement with Eisai Co., Ltd. to develop and commercialize a new transdermal formulation of donepe...

CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa

VIENNA, Va., March 9 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Alternext US: CVM) announced today that it has entered into an exclusive licensing agreement with Byron Biopharma ("Byron") under which CEL-SCI has granted Byron an exclusive license to market and distribute the Company's can...

Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development

ALISO VIEJO, Calif., March 3 /PRNewswire/ -- Bausch & Lomb, the global eye health company, has entered into a licensing agreement with Santen Pharmaceutical Co., Ltd., for the development of certain intraocular lens (IOL) materials. Under the terms of the agreement, Bausch & Lomb has...

Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression

EDISON, N.J., Feb. 23 /PRNewswire/ -- Nostrum Pharmaceuticals, LLC ("Nostrum"), a privately-held company based in Edison, New Jersey, announced today that it has obtained a worldwide license to develop and commercialize Caerulomycin A, and its proprietary derivatives and analogues ("Caerulomycin")...

Forest Laboratories, Inc. Reports Q3'09 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees

NEW YORK, Jan. 20, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX ), a U.S. based pharmaceutical company, today announced that reported diluted earnings per share equaled $0.62 in the third quarter of fiscal year 2009. Reported earnings per share include charges for new pro...

Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis

- Merck Serono and Apitope to Collaborate on Development and Commercialization of ATX-MS-1467, Apitope's Peptide Therapeutic for the Treatment of Multiple Sclerosis (MS) GENEVA, Jan. 13 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the signature o...

Rubicon Genomics Announces a Licensing Agreement With Abbott to Develop and Commercialize DNA Methylation Cancer Tests

ANN ARBOR, Mich., Jan. 12 /PRNewswire/ -- Rubicon Genomics today announced a licensing agreement with Abbott, which marks the achievement of significant milestones within their on-going Research and Option Agreement for development and commercialization of Rubicon MethylPlex(TM) methylation detect...

Alcohol and licensing policy could be changing the habits of young drinkers

In a new report published online today in the January issue of Addiction , researchers question whether current licensing policies have contributed to a rise in the phenomenon of "pre-drinking" amongst young people. "Pre-drinking" or "pre-gaming" involves planned heavy drinking, usually at som...

King Features Syndicate and Changing Times Vitamins Sign Licensing Agreement for Popeye(R) the Sailor Man in the Water Drink Category.

SCOTTSDALE, Ariz., Nov. 19 /PRNewswire-FirstCall/ -- Changing Times Vitamins, Inc., (Pink Sheets: SGTB) announced today that they have signed a licensing agreement with King Features Syndicate, Division of Hearst Corporation, one of the nation's largest diversified media companies. The license giv...

RecordGone.com Helps California Nurses Expunge Criminal Records to Meet More Stringent Licensing Standards

Last week the California Board of Registered Nursing unanimously passed more stringent standards that require nurses to submit fingerprints and undergo background checks when their license comes up for renewal every two years. RecordGone.com helps nurses expunge their criminal records, making it...

Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program

Program to Offer Licenses to Fundamental Fractional Patent Families MOUNTAIN VIEW, Calif. and BURLINGTON, Mass., Nov. 11 /PRNewswire/ -- Reliant Technologies, Inc. and Palomar Medical Technologies, Inc. (Nasdaq: PMTI) today announced the formation of a Fractional Technology Open Patent Progr...

Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program

Program to Offer Licenses to Fundamental Fractional Patent Families BURLINGTON, Mass., Nov. 11 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI ) and Reliant Technologies, Inc., today announced the formation of a Fractional Technology Open Patent Program ("FTOPP") ...

EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States

-- EMD Serono to acquire US rights in tesamorelin, a Phase III compound being investigated for the treatment of excess abdominal fat in HIV patients with lipodystrophy -- Theratechnologies to receive up to US$215 million plus increasing -- royalties on net sales in the US -- Me...

Derma Sciences Announces 3-Year Licensing Deals for Highly Profitable Character Strip Bandages

Immensely popular licensed characters will add significant growth to the company's first aid division PRINCETON, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI) announced today that it has secured two additional licenses to manufactu...

World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada

Econiche(TM) now available to reduce risk of food and water contamination BELLEVILLE, ON, Oct. 27 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that Econiche(TM), the world's first vacc...

Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives

- Barr Plans to Launch Generic Yasmin(R) on or before July 1, 2008 - Barr Plans to Launch Generic Yaz(R) on or before July 1, 2011 - Bayer to Continue Appeal of Yasmin(R) District Court Decision MONTVALE, N.J., June 24 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL )...

DOE Seeks Licensing Approval for Yucca Mountain Nuclear Waste Storage Site

169 million Americans currently live near temporary nuclear waste storage sites RED WING, Minn., June 5 /PRNewswire/ -- A Minnesota Indian tribe is again echoing the need for a national nuclear waste repository following the formal license application to build an...

Skinvisible Signs Licensing Agreement for Two Acne Formulations

New Retinoic Acid and Clindamycin Products Developed with Invisicare(R) LAS VEGAS, May 13 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI) ( http://www.skinvisible.com ), a research and development company focused on formulating enhanced patented dermatology products, ann...

C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks

Independent assessments worldwide verify safety and quality of technically advanced zirconium oxide material. DENVER, May 12 /PRNewswire/ -- C5 Medical Werks, a leading provider of ceramic solutions for the medical device industry, has submitted a 510(k) pre-market notificatio...

Linkwell Corporation Begins Training and Licensing Beijing Olympics Disinfection Teams

SHANGHAI, China, May 7 /Xinhua-PRNewswire-FirstCall/ -- Linkwell Corporation (Linkwell) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, announced today that its wholly owned subsidiary, Shanghai LiKang Disinfection Hi-...

Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment

COMPANY PROVIDES FY'09 EPS GUIDANCE OF APPROXIMATELY $3.10-$3.20 PER DILUTED SHARE NEW YORK, April 15 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX ), a U.S.-based pharmaceutical company, today announced that fully diluted earnings per share (EPS...

Medical Futures signs North American licensing rights to New Biologic agent for Ulcerative Colitis

TORONTO, April 7 /PRNewswire/ - Medical Futures Inc. has licensed MUTAFLOR(R) for the North American market. MUTAFLOR(R) is a drug used in remission maintenance of Ulcerative Colitis. Since its discovery in 1917, MUTAFLOR(R) has been available in the German marketplace through a subsidiary of ...

Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel

BERKELEY HEIGHTS, N.J., March 7 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA ) announced today the Company has entered into an exclusive worldwide licensing agreement with Daiichi Sankyo Company, Limited (TYO: 4568) for the development and commercialization of tesetaxel (formerl...

Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement

Broad-based alliance to develop products for a wide range of animal species PLEASANTON, Calif., March 4 /PRNewswire/ -- The Animal Health Division of Bayer HealthCare AG and Juvaris BioTherapeutics, Inc. jointly announced today that the companies have executed a broad-based licensing agreement. ...

Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program

An affordable dental/health care initiative to put an end to toothaches PHILADELPHIA, Feb. 20 /PRNewswire/ -- Emergency Dentist 24/7(TM), cutting edge health care model, based in Philadelphia, announced that it is expanding its program, the first of its kind, by offering licensing opportunitie...

Dblur Concludes Licensing Deal With STMicroelectronics

STMicroelectronics Integrates Dblur's Software Lens(TM) Technology Into its Image Sensors HERZLIYA, Israel, February 11 /PRNewswire/ -- Dblur, the developer of Software Lens(TM) technology, today announced a strategic cooperation with STMicroelectronics (NYSE: STM ), ...

Skinvisible Announces Licensing Agreement for Adapalene

The Company's first acne product enters the $2.8 billion worldwide market LAS VEGAS, Jan. 30 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI; http://www.skinvisible.com ), a research and development company focused on formulating and enhancing patented dermatology product...

Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova

LAVAL, QC, Jan. 24 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS, NASDAQ: DDSS) today announced that it has entered into a licensing and distribution agreement with iNova Pharmaceuticals (Australia) Pty Limited for its once-daily tramadol product for Australia. "Building on the launch of...

Campbell Alliance Business Development Practice Leader to Co-Chair and Keynote at SRI Pharma Licensing Summit

RALEIGH, N.C., Dec. 5 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that Ben Bonifant, Vice President of the firm's Business Development practice, will serve as conference chairperson a...

Datasci and etrials Worldwide Announce Settlement in Patent Dispute; Licensing Agreement Now in Place

OLNEY, Md., Nov. 27 /PRNewswire/ -- Datasci, LLC and etrials Worldwide, Inc. announced today that their pending patent litigation has been settled. The lawsuit, which is related to Datasci's U.S. Patent Number 6,496,827, concerned the collection and validation of clinical trial data. Under the...

Cash Technologies Subsidiary Signs Services and Licensing Agreement With Health Payment Systems

LOS ANGELES, Nov. 9 /PRNewswire-FirstCall/ -- Cash Technologies, Inc. (Amex: TQ ) announced that its wholly owned subsidiary, Claim-Remedi Services, Inc. has entered into a Services Agreement (the "Agreement") with Health Payment Systems, Inc. ("HPS") to market Claim-Remedi's healthcare reven...

Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University

Contracts Establish Exclusive Access to Diagnostic Application of Research Discoveries FULLERTON, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that it has signed two agreements with Johns Hopkins University giving the...

Cash Technologies Subsidiary Signs Services and Licensing Agreement With TriCap Health Group

LOS ANGELES, Oct. 25 /PRNewswire-FirstCall/ -- Cash Technologies, Inc. (Amex: TQ ) announced that its wholly owned subsidiary, Claim-Remedi Services, Inc. has entered into a Services Agreement (the "Agreement") with TriCap Health Group, LLC to incorporate Claim-Remedi's products into TriCap's...